Cannabidiol (CBD) as a Promising Anti-Cancer Drug

Author(s)

Seltzer, E. S., Watters, A. K., MacKenzie, D., Jr., Granat, L. M., & Zhang, D.

Title

Cannabidiol (CBD) as a Promising Anti-Cancer Drug

Date

2020

Publisher

MDPI AG

Subject

CBD
Cannabidiol
Cannbinoids
Anti-cancer drug

Language

English

Abstract

Recently, cannabinoids, such as cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC), have been the subject of intensive research and heavy scrutiny. Cannabinoids encompass a wide array of organic molecules, including those that are physiologically produced in humans, synthesized in laboratories, and extracted primarily from the Cannabis sativa plant. These organic molecules share similarities in their chemical structures as well as in their protein binding profiles. However, pronounced differences do exist in their mechanisms of action and clinical applications, which will be briefly compared and contrasted in this review. The mechanism of action of CBD and its potential applications in cancer therapy will be the major focus of this review article.

Source

Cancers, Volume 12, Issue 11, October 2020, page 3203

Rights

© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Format

PDF

Type

Text

Bibliographic Citation

Seltzer, E. S., Watters, A. K., MacKenzie, D., Jr., Granat, L. M., & Zhang, D. (2020). Cannabidiol (CBD) as a Promising Anti-Cancer Drug. In Cancers (Vol. 12, Issue 11, p. 3203). MDPI AG. https://doi.org/10.3390/cancers12113203

Files

cancers-12-03203-v2.pdf

Citation

Seltzer, E. S., Watters, A. K., MacKenzie, D., Jr., Granat, L. M., & Zhang, D. , Cannabidiol (CBD) as a Promising Anti-Cancer Drug. Cancers, Volume 12, Issue 11, October 2020, page 3203, New York Tech Institutional Repository, accessed April 28, 2024, https://repository.nyitlibrary.org/items/show/3762

Position: 505 (7 views)